Latest Tiffany & Co News

FILE - In this Jan. 28, 2020 file photo, CEO of LVMH Bernard Arnault presents the group's 2019 results during a press conference, in Paris. The luxury goods giant is ending its takeover deal of luxury jewelry retailer Tiffany & Co., citing in part the threat of proposed U.S. tariffs on French goods.  (AP Photo/Thibault Camus, File)

Dueling over diamonds: LVMH says Tiffany not worth buyout

Sep. 10, 2020 9:11 AM EDT

PARIS (AP) — It's an ugly spat for such a glamorous industry: French luxury powerhouse LVMH and U.S. jeweler Tiffany & Co. are blaming each other for the collapse of what would have been the sector's biggest-ever buyout deal. Paris-based LVMH had announced Wednesday it was abandoning the $14.5 billion...

FILE - In this Nov.25, 2019 file photo, the logo of Tiffany jeweler shop is pictured on the Champs Elysees avenue in Paris. LVMH is ending its monthslong pursuit of luxury jewelry retailer Tiffany & Co., citing in part the impact of proposed tariffs on French goods. The Paris-based conglomerate said that it needs more time to assess the impact of U.S. tariffs on French goods and cannot close the deal before year-end. (AP Photo/Michel Euler, File)

Luxury goods giant LVMH cancels $14.5B deal for Tiffany

Sep. 9, 2020 6:27 PM EDT

NEW YORK (AP) — Luxury goods giant LVMH is ending its takeover deal of jewelry retailer Tiffany & Co., saying the French government had requested a delay to assess the threat of proposed U.S. tariffs. Wednesday's announcement came after the deal's value had been eroded by wider industry troubles caused...

Intra-Cellular, Qorvo rise; Slack, Tiffany fall

Sep. 9, 2020 4:37 PM EDT

NEW YORK (AP) — Stocks that moved heavily or traded substantially Wednesday: AstraZeneca Plc., down $1.07 to $53.64. The drug developer halted late-stage studies of its potential COVID-19 vaccine to investigate a “potentially unexplained” illness. Mastercard Inc., up $9.76 to $339.64. The...

J.M. Smucker, Amgen rise; Tiffany, Best Buy fall

Aug. 25, 2020 4:20 PM EDT

NEW YORK (AP) — Stocks that moved heavily or traded substantially Tuesday: Immunovant Inc., up $1.18 to $34.66. The biotechnology company reported encouraging results from a study of its potential treatment for a muscle fatigue condition. Amgen Inc., up $12.65 to $248.22. The biotechnology giant will be...